Sowell Financial Services’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Sowell Financial Services’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,268	Closed	-$357K	–	861
2023 Q1	$357K	Buy	+3,268	New	+$361K	0.03%	518
2021 Q3	–	Sell	-11,158	Closed	-$1.04M	–	574
2021 Q2	$1.04M	Buy	11,158 +18	+0.2%	+$1.66K	0.07%	296
2021 Q1	$1M	Buy	11,140 +2,687	+32%	+$227K	0.03%	412
2020 Q4	$618K	Sell	8,453 -3,198	-27%	-$238K	0.03%	455
2020 Q3	$905K	Buy	11,651 +10,601	+1,010%	+$729K	0.05%	319
2020 Q2	$58K	Buy	1,050 +1,000	+2,000%	+$42.8K	﹤0.01%	1130
2020 Q1	$1K	Hold	50	–	–	﹤0.01%	2383
2019 Q4	$2K	Hold	50	–	–	﹤0.01%	2274
2019 Q3	$1K	Buy	+50	New	+$1.29K	﹤0.01%	2371

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Sowell Financial Services's HZNP Position: Q2 2023 in Review

Sowell Financial Services sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 3,268 shares — an estimated $357K sold.

Sowell Financial Services first reported a position in HZNP in Q3 2019 and held it in 9 quarters. The position peaked at $1.04M in Q2 2021. 517 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Sowell Financial Services reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Sowell Financial Services sold 3,268 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $357K.
Sowell Financial Services first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2019 and held it in 9 quarters.
Sowell Financial Services's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $1.04M in Q2 2021.
517 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Sowell Financial Services's 13F filing for Q2 2023, filed 14 Aug 2023.